Skip to main content

Advertisement

Log in

Neurotrophic factor expression in childhood low-grade astrocytomas and ependymomas

  • Original Paper
  • Published:
Child's Nervous System Aims and scope Submit manuscript

Abstract

Background

Neurotrophic factors (nerve growth factor [NGF], brain-derived neurotrophic factor [BDNF] and glial-derived neurotrophic factor [GDNF]) are growth factors implicated in the growth and differentiation of brain nerve cells. An involvement of these factors in the biology and progression of some specific tumours has been suggested. In accordance with the role of neurotrophic factors in tumour behaviour the aim of the present study was to investigate their expression in two childhood brain neoplasms, namely low-grade astrocytomas and ependymomas.

Materials and methods

We investigated the NGF, BDNF, GDNF and NGF receptors (TrkA and p75) expression in the tumour tissues, cerebrospinal fluid (CSF) and plasma of ten children affected by low-grade astrocytomas and ependymomas. Control tissue samples (together with CSF and plasma samples) were obtained from patients who underwent surgery for cerebral vascular or epileptogenic lesions.

Results

The expression of NGF decreases both in tumour samples and in the CSF of affected children compared with controls. BDNF instead increases in CSF, while the expression of GDNF remains unchanged both in tissues and in CSF. No differences were found in neurotrophic factor plasma levels in patients or in controls. Gene expression of NGF and its high-affinity receptor (TrkA) are reduced in tumour tissues, whereas the number of cells immunopositive to the low-affinity NGF receptor (p75) is increased.

Conclusion

Reduced expression of NGF and TrkA has been shown in low-grade astrocytomas and ependymomas. These findings may be related to the role of this neurotrophin in cell differentiation and apoptosis. The different expression of NGF, BDNF, and GDNF in low-grade astrocytomas and ependymomas suggests that a different degree of redundancy exists among members of the neurotrophic factor family and that their expression may be correlated with the biology and the behaviour of these tumours.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1a, b
Fig. 2a, b
Fig. 3
Fig. 4a–d
Fig. 5a, b
Fig. 6a, b

Similar content being viewed by others

Michael Weller, Wolfgang Wick, … Guido Reifenberger

References

  1. Aloe L, Tirassa P, Bracci-Laudiero L (2001) Nerve growth factor in neurological and non-neurological diseases: basic findings and emerging pharmacological prospectives. Curr Pharm Des 7:113–123

    CAS  PubMed  Google Scholar 

  2. Baloh RH, Enomoto H, Johnson EM Jr, Milbrandt J (2000) The GDNF family ligands and receptors implications for neural development. Curr Opin Neurobiol 10:103–110

    CAS  PubMed  Google Scholar 

  3. Barde YA (1994) Neurotrophins: a family of proteins supporting the survival of neurons. Prog Clin Biol Res 390:45–56

    CAS  PubMed  Google Scholar 

  4. Chao MV, Hempstead BL (1995) P75 and Trk: a two receptor system. Trends Neurosci 18:321–326

    Article  CAS  PubMed  Google Scholar 

  5. Chiappa SA, Phil D, Chin LS, Zurawel RH, Raffel C (1999) Neurotrophins and Trk receptors in primitive neuroectodermal tumor cell lines. Neurosurgery 45:1148–1153

    CAS  PubMed  Google Scholar 

  6. Colucci-D’Amato GL, D’Alessio A, Califano D, Cali G, Rizzo C, Nitsch L, Santelli G, de Franciscis V (2000) Abrogation of nerve growth factor-induced terminal differentiation by ret oncogene involves perturbation of nuclear translocation of ERK. J Biol Chem 275:19306–19314

    Article  CAS  PubMed  Google Scholar 

  7. Connor B, Dragunow M (1998) The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Res Rev 27:1–39

    Article  CAS  PubMed  Google Scholar 

  8. Declercq W, Denecker G, Fiers W, Vandenabeele P (1998) Cooperation of both TNF receptors in inducing apoptosis: involvement of the TNF receptor-associated factor binding domain of the TNF receptor 75. J Immunol 161:390–399

    CAS  PubMed  Google Scholar 

  9. Devouassoux-Shisheboran M, Mauduit C, Tabone E, Droz JP, Benahmed M (2003) Growth regulatory factors and signalling proteins in testicular germ cell tumours. APMIS 111:212–224

    Article  CAS  PubMed  Google Scholar 

  10. Drago J, Kilpatrick TJ, Koblar SA, Talman PS (1994) Growth factor: potential therapeutic applications in neurology. J Neurol Neurosurg Psychiatry 57:1445–1450

    CAS  PubMed  Google Scholar 

  11. Ebadi M, Bashir RM, Heidrick ML, Hamada FM, Refaey HE, Hamed A, Helal G, Baxi MD, Cerutis DR (1997) Neurotrophins and their receptors in nerve injury and repair. Neurochem Int 30:347–374

    Article  CAS  PubMed  Google Scholar 

  12. Eberhart CG, Kaufman WE, Tihan T, Burger PC (2001) Apoptosis, neuronal maturation and neurotrophin expression within medulloblastoma nodules. J Neuropathol Exp Neurol 60:462–469

    Google Scholar 

  13. Eggert A, Sieverts H, Ikegaki N, Brodeur GM (2000) p75 mediated apoptosis in neuroblastoma cells is inhibited by expression of TrkA. Med Pediatr Oncol 35:573–576

    Article  CAS  PubMed  Google Scholar 

  14. Goss JR, O’Malley ME, Zou L, Styren SD, Kochanek PM, DeKosky ST (1998) Astrocytes are the major source of nerve growth factor upregulation following traumatic brain injury in the rat. Exp Neurol 149:301–309

    Article  CAS  PubMed  Google Scholar 

  15. Green LA, Tischler AS (1976) Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA 73:2424–2428

    CAS  PubMed  Google Scholar 

  16. Grotzer MA, Janss AJ, Fung K, Biegel JA, Sutton LN, Rorke LB, Zhao H, Cnaan A, Phillips PC, Lee VM, Trojanowski JQ (2000) TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors. J Clin Oncol 18:1027–1035

    CAS  PubMed  Google Scholar 

  17. Keles GE, Berger MS, Schofield D, Bothwell M (1993) Nerve growth factor receptor expression in medulloblastomas and the potential role of the nerve growth factor as a differentiating agent in medulloblastomas cell lines. Neurosurgery 32:274–280

    CAS  PubMed  Google Scholar 

  18. Kimura S, Yoshino A, Katayama Y, Watanabe T, Fukushima T (2002) Growth control of C6 glioma in vivo by nerve growth factor. J Neurooncol 59:199–205

    Article  Google Scholar 

  19. Kokunai T, Iguchi H, Tamaki N (1998) Differentiation and growth inhibition of glioma cells induces by transfer of trkA proto-oncogene. Oncogene 16:3253–3260

    Article  PubMed  Google Scholar 

  20. Korsching S, Auburger G, Heumann R, Scott J, Thoenen H (1985) Level of nerve growth factor and its mRNA in the central nervous system of the rat correlate with cholinergic innervation. EMBO J 4:1389–1393

    CAS  PubMed  Google Scholar 

  21. Kowalski PJ, Paulino AF (2002) Perineural invasion in adenoid cystic carcinoma: its causation/promotion by brain-derived neurotrophic factor. Hum Pathol 33:933–936

    CAS  PubMed  Google Scholar 

  22. Levi-Montalcini R (1987) The nerve growth factor 35 years later. Science 4:1154–1162

    Google Scholar 

  23. Lewin G, Barde YA (1996) Physiology of the neurotrophins. Annu Rev Neurosci 19:289–317

    CAS  PubMed  Google Scholar 

  24. MacPhee IJ, Barker PA (1995) Brain-derived neurotrophic factor binding to the p75 neurotrophin receptor reduces TrkA signalling while increasing serine phosphorylation in the TrkA intracellular domain. J Biol Chem 272:23547–23551

    Article  Google Scholar 

  25. Nakagawara A, Nakagawara AM, Scavarda NJ, Azar CG, Cantor AB, Brodeur GM (1993) Association between high levels of expression of the Trk gene and favourable outcome in human neuroblastoma. N Engl J Med 328:847–854

    Article  CAS  PubMed  Google Scholar 

  26. Nishio S, Morioka T, Hamada Y, Fukui M, Nakagawara A (1998) Immunohistochemical expression of tyrosine kinase (Trk) receptor proteins in mature neuronal cell tumors of the central nervous system. Clin Neuropathol 17:123–130

    CAS  PubMed  Google Scholar 

  27. Segal RA, Goumnerova LC, Kwon YK, Stiles CD, Pomeroy SL (1994) Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma. Proc Natl Acad Sci USA 91:12867–12871

    CAS  PubMed  Google Scholar 

  28. Sofroniew MV, Howe CL, Mobley WC (2001) Nerve growth factor signalling, neuroprotection, and neural repair. Annu Rev Neurosci 24:1217–1281

    Article  CAS  PubMed  Google Scholar 

  29. Thoenen H, Bandtlow C, Heumann R (1987) The physiological function of nerve growth factor in the central nervous system: comparison with the periphery. Rev Physiol Biochem 109:145–178

    CAS  PubMed  Google Scholar 

  30. Tuveri M, Generini S, Matucci-Cerinic M, Aloe L (2000) NGF, a useful tool in the treatment of chronic vasculitic ulcers in rheumatoid arthritis. Lancet 356:1739–1740

    Article  CAS  PubMed  Google Scholar 

  31. Verity AN, Wyatt TL, Lee W, Hajos B, Baecker PA, Eglen RM, Johnson RM (1999) Differential regulation of glial cell line-derived neurotrophic factor (GDNF) expression in human neuroblastoma and glioblastoma cell lines. J Neurosci Res 55:187–197

    Article  CAS  PubMed  Google Scholar 

  32. Wadhwa S, Nag TC, Jindal A, Kushwaha R, Mahapatra AK, Sarkar C (2003) Expression of the neurotrophin receptors Trk A and Trk B in adult human astrocytoma and glioblastoma. J Biosci 28:181–188

    CAS  PubMed  Google Scholar 

  33. Wiesenhofer B, Stockhammer G, Kostron H, Maier H, Hinterhuber H, Humpel C (2000) Glial cell line-derived neurotrophic factor (GDNF) and ist receptor (GFR-alpha1) are strongly expressed in human gliomas. Acta Neuropathol (Berl) 99:131–137

    Google Scholar 

Download references

Acknowledgements

This study was supported by Consiglio Nazionale delle Ricerche and Fondazione CARISBO, Bologna, to Luigi Aloe, and by the Project on Neurotrophic Factor Expression, MIUR 2003, from the Catholic University Medical School of Rome, Italy, to Concezio Di Rocco.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Antonio Chiaretti.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chiaretti, A., Aloe, L., Antonelli, A. et al. Neurotrophic factor expression in childhood low-grade astrocytomas and ependymomas. Childs Nerv Syst 20, 412–419 (2004). https://doi.org/10.1007/s00381-004-0959-6

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00381-004-0959-6

Keywords

Navigation